Wilson Sonsini Goodrich & Rosati and Goodwin Procter LLP advised Centessa Pharmaceuticals on the deal. Centessa Pharmaceuticals, a clinical-stage company employing its innovative asset-centric business model…
- Homepage
- North America
- North America Legal Chronicle
- Centessa Pharmaceuticals’ $330 Million IPO
Centessa Pharmaceuticals’ $330 Million IPO
Tagged: Alex Apostolopoulos Andrew Hess Andy Barton Asta Evans Benjamin Bertan Brittany McCants Centessa Pharmaceuticals Limited Chloe Smith Christina Susanto Delphine O'Rourke Edwin O’Connor Goodwin Procter Graham Defries Heath Ingram James Xu Julia Minitti Kenny Walker-Durrant Lily Wound Michael Hostetler Mitchell Bloom Pablo Hernandez Romero Paresh Kumar Robert Young Sarah Wicks Simone Otenaike Stephanie Philbin Wilson Sonsini Goodrich & Rosati
Author: Martina Bellini
…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here